These findings open the door to using this type of cells to treat human illnesses like heart attacks and strokes.
More than 300 professionals participated in an event to boost entrepreneurialism in hospitals and research centers on 10 December.
This is the first Spanish hospital to offer a ‘single window’ service to manage and coordinate internal and external clinical trials in pediatrics.
This Catalan biomedical firm increased capital by €3 millions, with investment from Inveready and Reiman Inversiones, in order to boost their R&D area in oncology.
This joint initiative of COMB, Cecot and Biocat will be presented on 10 December in Barcelona.
Creada per iniciativa de l'Institut Carlos III, l'integren 14 centres hospitalaris de tot l’Estat espanyol, dels quals 6 són catalans.
Created two years ago, this network is made up of 14 hospital centers from around Spain, 6 of which are Catalan.
President of the Government of Catalonia highlights that the Institut Guttmann slogan 'Helping start new lives’ is a positive message that can help drive the country towards a future full of encouraging challenges and collective projects.
The contest Valortec ACC1Ó and university evaluation units drive technology to the market.
Baselga is also Physician-in-Chief at the Vall d'Hebron Institute of Oncology (VHIO) in Barcelona and Chief of the Division of Oncology/Hematology at Massachusetts General Hospital in Boston.
They have discovered 15 compounds to fight breast and prostate cancer, which in some cases are twice as effective and up to 70% less toxic.
Developed by Drauta